| Holding(s) in Company | 28-May-2026 | 14:35 | RNS |
| Result of Placing | 22-May-2026 | 10:11 | RNS |
| Proposed Placing to raise approximately £5.5m | 22-May-2026 | 07:02 | RNS |
| FY25 Final Results | 22-May-2026 | 07:01 | RNS |
| Proposed Sale of 49% Interest in Creo Medical SL | 22-May-2026 | 07:00 | RNS |
| Positive Q1 trading update | 22-Apr-2026 | 07:00 | RNS |
| Disposal and outsourcing of manufacturing | 16-Apr-2026 | 07:00 | RNS |
| Appointment of Joint Corporate Broker | 24-Feb-2026 | 07:00 | RNS |
| FY25 Trading Update | 20-Jan-2026 | 07:00 | RNS |
| Award of Shares under Share Incentive Plan | 14-Jan-2026 | 07:00 | RNS |
| Notice of Capital Markets Day | 27-Oct-2025 | 07:00 | RNS |
| Capital Markets Day update | 07-Oct-2025 | 11:37 | RNS |
| Unaudited results for the six months ended 30 June | 22-Sep-2025 | 07:00 | RNS |
| Holding(s) in Company | 12-Sep-2025 | 15:14 | RNS |
| Notice of Results | 11-Sep-2025 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 14.13p |
| Change Today | 0.18p |
| % Change | 1.25 % |
| 52 Week High | 17.75 |
| 52 Week Low | 9.90 |
| Volume | 2,132,770 |
| Shares Issued | 449.14m |
| Market Cap | £63.44m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
| Time | Volume / Share Price |
| 11:07 | 1,000,000 @ 14.20p |
| 16:37 | 10,000 @ 14.00p |
| 16:29 | 26,595 @ 14.00p |
| 16:25 | 10,000 @ 14.03p |
| 16:19 | 3 @ 14.25p |
| CEO | Craig Jonathan Gulliford |
| CFO | Richard John Rees |
| Chair | Kevin Crofton |
You are here: research